BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
50.38
+1.29 (2.63%)
At close: Aug 13, 2025, 4:00 PM
50.46
+0.08 (0.16%)
After-hours: Aug 13, 2025, 7:52 PM EDT
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $9.63 billion as of August 13, 2025. Its market cap has increased by 95.92% in one year.
Market Cap
9.63B
Enterprise Value
10.73B
1-Year Change
95.92%
Ranking
Category
Stock Price
$50.38
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $9.63B, an increase of 190.11%. That is a compound annual growth rate of 18.96%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |